J Diabetes. 2020;12(9):645-648.
Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease.
제1저자 문선준 · 교신저자 조영민
소속 (3)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Abstract
Highlights Based on nationwide insurance data in Korea, the use of dipeptidyl peptidase IV inhibitors (DPP-IVi) not requiring renal dose adjustment (NRDA DPP-IVi) is widespread in the type 2 diabetes chronic kidney disease (T2D CKD) population. Instead of prescribing NRDA DPP-IVi, the use of DPP-IVi requiring renal dose adjustment with appropriate renal dose adjustments in T2D CKD patients can achieve a considerable annual cost saving of up to 7.8%.
© 2020 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.
Keywords
cost analysisdipeptidyl peptidase IV inhibitorsrenal insufficiency二肽基肽酶IV抑制剂成本分析肾功能不全
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- Journal of diabetes · eISSN 1753-0407
- 전자 출판
- 2020-06-25
- MeSH
- Adult · Biomarkers / analysis · Blood Glucose / analysis · Cost-Benefit Analysis* · Diabetes Mellitus, Type 2 / complications / drug therapy / economics / pathology · Diabetic Nephropathies / drug therapy / economics / etiology · Dipeptidyl Peptidase 4 / chemistry · Dipeptidyl-Peptidase IV Inhibitors / economics / therapeutic use · Dose-Response Relationship, Drug · Drug Dosage Calculations · Female · Follow-Up Studies · Glycated Hemoglobin / analysis · Health Care Costs* · Humans · Male · Prognosis · Renal Insufficiency, Chronic / drug therapy / economics / etiology · Young Adult
- Substances
- Biomarkers · Blood Glucose · Dipeptidyl Peptidase 4 · Dipeptidyl-Peptidase IV Inhibitors · Glycated Hemoglobin · hemoglobin A1c protein, human · DPP4 protein, human